A Prospective Phase II Study of a New Treatment Protocol for NSCLC Combined with Preoperative Mediastinoscopy and Chemotherapy

Abstract

Background: We have developed a new multimodal treatment protocol combined with video-assisted mediastinoscopy (VAM) and chemotherapy. Methods: Forty-four pN2 non-small cell lung cancer (NSCLC) cases were selected from the surgically treated groups and the prognoses were compared between October 1998 and December 2004. Patients negative for nodes on examination by VAM (VAM-negative: group 2) underwent thoracotomy, and those positive for nodes (VAM-positive) received induction chemotherapy. After chemotherapy, only patients who met the surgical criteria underwent thoracotomy (group 3), and the remaining cases were allocated to radiotherapy (group 4) or best supportive care. When none of the VAM criteria were met (group 1), thoracotomy was performed without VAM. Results: The overall 3- and 5-year survival rates were 42.1 % and 28.0 %. The survival rates in groups 2 and 3 were almost the same (p = 0.5392), even though there were significantly more patients with multiple N2 stations in group 3 (p = 0.0088). Conclusions: Preoperative detection of lymph node metastasis by VAM makes use of the benefits of surgical intervention, and adjuvant therapies improve the survival of NSCLC patients with N2 disease.

cardiovascular surgery - heart and lung transplantation - thoracic surgery

References

• 1 American College of Chest Physicians . Diagnosis and management of lung cancer: ACCP evidence-based guidelines. American College of Chest Physicians.  Chest. 2003;  123 (Suppl 1) S1-S337
• 2 Friedel G, Steger V, Kyriss T. et al . Prognosis in N2 NSCLC.  Lung Cancer. 2004;  45 (Suppl 2) S45-S53
• 3 Robinson L A, Wagner Jr H, Ruckdeschel J C. American College of Chest Physicians . Treatment of stage IIIA non-small cell lung cancer.  Chest. 2003;  123 (Suppl 1) S202-S220
• 4 Riquet M, Assouad J, Bagan P. et al . Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.  Ann Thorac Surg. 2005;  79 225-233
• 5 Andre F, Grunenwald D, Pignon J P. et al . Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.  J Clin Oncol. 2000;  18 2981-2989
• 6 Inoue M, Sawabata N, Takeda S. et al . Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.  J Thorac Cardiovasc Surg. 2004;  127 1100-1106
• 7 Kimura H, Iwai N, Ando S. et al . A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size and tumor markers.  Ann Thorac Surg. 2003;  75 1734-1739
• 8 Ando S, Kimura H, Iwai N. et al . The significance of tumor markers as an indication for mediastinoscopy in non-small cell lung cancer.  Respirology. 2003;  8 163-167
• 9 Kimura H, Dobrenkov K, Iida T. et al . Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.  Anticancer Res. 2005;  25 85-94
• 10 Kimura H, Yamaguchi Y. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.  Cancer. 1997;  80 42-49
• 11 Kimura H, Yamaguchi Y. Adjuvant chemo-immunotherapy after curative resection of stage II and IIIA primary lung cancer.  Lung Cancer. 1996;  14 301-314
• 12 Giannitto G C, Giuffrida D, Pappalardo A. et al . Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.  Oncology. 2005;  69 295-300
• 13 Berghmans T, Paesmans M, Meert A P. et al . Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.  Lung Cancer. 2005;  49 13-23
• 14 De Marinis F, Gebbia V, De Petris L. Neoadjuvant chemotherapy for stage IIIA‐N2 non-small cell lung cancer.  Ann Oncol. 2005;  16 (Suppl 4) iv116-iv122
• 15 Choi Y S, Shim Y M, Kim J. et al . Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer.  Eur J Cardiothorac Surg. 2002;  22 695-700
• 16 Ichinose Y, Kato H, Koike T. et al . Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.  J Thorac Cardiovasc Surg. 2001;  122 803-808
• 17 Vansteenkiste J F, De Leyn P R, Deneffe G J. et al . Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases.  Ann Thorac Surg. 1997;  63 1441-1450
• 18 Tanaka F, Yanagihara K, Otake Y. et al . Prognostic factors in resected pathologic (p-) stage IIIA‐N2 non-small-cell lung cancer.  Ann Surg Oncol. 2004;  11 612-618
• 19 Mouroux J, Venissac N, Alifano M. Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer.  Ann Thorac Surg. 2001;  72 1698-1704
• 20 Gephardt G N, Rice T W. Utility of frozen-section evaluation of lymph nodes in the staging of bronchogenic carcinoma at mediastinoscopy and thoracotomy.  J Thorac Cardiovasc Surg. 1990;  100 853-859
• 21 Rooker S, Van Schil P, Van den Brande F. et al . Current outcome in patients with lung cancer and positive mediastinoscopy.  Acta Chir Belg. 2001;  101 273-276
• 22 De Leyn P, Vansteenkiste J, Deneffe G. et al . Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.  Eur J Cardiothorac Surg. 1999;  15 608-614
• 23 Vilmann P, Krasnik M, Larsen S S. et al . Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS‐FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions.  Endoscopy. 2005;  37 833-839
• 24 Herth F J, Lunn W, Eberhardt R. et al . Transbronchial versus transesophageal ultrasound-guided aspiration of enlarged mediastinal lymph nodes.  Am J Respir Crit Care Med. 2005;  171 1164-1167
• 25 Yasufuku K, Chiyo M, Koh E. et al . Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.  Lung Cancer. 2005;  50 347-354
• 26 Yasufuku K, Nakajima T, Motoori K. et al . Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.  Chest. 2006;  130 710-718